tuftsin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-14 and is reviewed periodically as new material appears.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
| Property | Value | Notes |
|---|---|---|
| Solubility | Freely soluble in water | Also in aqueous buffers |
| Typical purity (HPLC) | 95 percent or higher | Lot-dependent |
| Dry powder storage | Minus 20 degrees Celsius | Sealed, dry, protected from light |
| Solution storage | 2 to 8 degrees Celsius | Short-term use |
| Identity confirmation | Mass spectrometry | ESI or MALDI-TOF |
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.
== See also == Targeted therapy Nanomedicine Nanobiotechnology § Nanomedicine Antibody-drug conjugate Retrometabolic drug design Magnetic drug delivery PH-responsive tumor-targeted drug delivery Erythrocyte-based drug delivery Electro-responsive drug delivery
The Times reported that while one child in 20 in Shanghai could have kidney damage as a result of drinking contaminated formula milk, on the other hand, "like the emperors of old, the new communist elite enjoy the finest produce from all over China, sourced by a high-security government department." Access Asia, a Shanghai-based consumer consultancy, said Fonterra was an example of western executives in China "believ[ing] advice in business books that they must avoid making their local partners 'lose face' at all costs". It suggested that Fonterra paid the price for this both financially and in damage to their reputation. Caijing said the crisis revealed that there had been a "serious dereliction of duty" at the AQSIQ, and that the government had failed as a "night watchman". Citing public consensus that government should limit itself to a supervisory role, it urged the construction of a regulatory system which addressed the role of regulators watching over the production process, avoiding over-regulation, 'regulatory capture' and abuse of power by regulators. "Keeping the market in order and ensuring independent law enforcement should be part of the mandate."
== Function == The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated by, and mediates the responses of many cell ligands, such as IL2, IL3, IL7 GM-CSF, erythropoietin, thrombopoietin, and different growth hormones. Activation of this protein in myeloma and lymphoma associated with a TEL/JAK2 gene fusion is independent of cell stimulus and has been shown to be essential for the tumorigenesis. The mouse counterpart of this gene is found to induce the expression of BCL2L1/BCL-X(L), which suggests the antiapoptotic function of this gene in cells. It also transduces prolactin signals to the milk protein genes and is necessary for mammary gland development.
==== 800–899 ==== South Eastern Combined Fire Area Administration (Amendment) (No. 2) Scheme Order 1993 (S.I. 1993/800) Greater London and Kent (County Boundaries) (Variation) Order 1993 (S.I. 1993/805) Pensions Increase (Civil Service Early Retirement Pension Scheme 1992) Regulations 1993 (S.I. 1993/806) Injuries in War (Shore Employments) Compensation (Amendment) Scheme 1992 S.I. 1993/807) Devon Ambulance Service National Health Service Trust Dissolution Order 1993 (S.I. 1993/809) Cornwall Community Healthcare National Health Service Trust Dissolution Order 1993 (S.I. 1993/810) Walsgrave Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/811) Walsgrave Hospital National Health Service Trust Dissolution Order 1993 (S.I. 1993/812) Cornwall Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/813) Westcountry Ambulance Services National Health Service Trust (Establishment) Order 1993 (S.I. 1993/814) Reconstitution of the Romney Marsh Levels Internal Drainage Board Order 1993 (S.I. 1993/815) Reconstitution of the Finningley Internal Drainage Board Order 1993 (S.I. 1993/816) Reconstitution of the River Stour (Kent) Internal Drainage Board S.I. 1993/817) Civil Legal Aid (Scotland) Amendment (No.2) Regulations 1993 (S.I. 1993/818) Advice and Assistance (Scotland) Amendment (No.2) Regulations 1993 (S.I. 1993/819) Harefield Hospital National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/820) Social Security (Contributions) Amendment (No. 5) Regulations 1993 (S.I.
Sources: en.wikipedia.org
=== Economics === First-in-class drugs are often seen as commercially more attractive as they may tap into a market segment that has hitherto been underserved, but this may be illusory. In fact, most blockbuster drugs (drugs with annual sales revenues exceeding US$1,000,000,000) were not first-in-class drugs. The economic potential of a first-in-class drug, which is typically priced higher than later drugs in the same class, has been largely declining due to efforts by health insurers to restrict what specialty drugs are covered and prevent incumbency advantages.
==== Intermolecular forces ==== Nanoparticles can self-assemble as a result of their intermolecular forces. As systems look to minimize their free energy, self-assembly is one option for the system to achieve its lowest free energy thermodynamically. Nanoparticles can be programmed to self-assemble by changing the functionality of their side groups, taking advantage of weak and specific intermolecular forces to spontaneously order the particles. These direct interparticle interactions can be typical intermolecular forces such as hydrogen bonding or Van der Waals forces, but can also be internal characteristics, such as hydrophobicity or hydrophilicity. For example, lipophilic nanoparticles have the tendency to self-assemble and form crystals as solvents are evaporated. While these aggregations are based on intermolecular forces, external factors such as temperature and pH also play a role in spontaneous self-assembly.
== Peptides vs proteins and amino acids in the digestive tract == Any animal that consumes a whole protein must break down and digest the protein order to absorb the nutrients. For humans this begins with chewing and the addition of saliva enzymes, followed by acid and protease enzyme digestion in the stomach, whereby the end result is a peptide or amino acid fraction ready for uptake into the blood stream via the small intestine. Research has confirmed that most animals have more Peptide receptors in the gut and lower intestine than they do free amino acid receptors - as such the peptide form of fish protein powder is most conducive for optimal nutritional benefits. Hygienic production of fish protein powder mimics these natural digestion steps, and pending the degree of hydrolysis, the protein powder will actually be a partial or complete peptide powder, ready for immediate absorption in the intestine.
== Further reading == Al-Hussainy, Abbas Ali Abbas, "The civilized achievements of the Akkadian king Naram-Sin A Research in his Artistic Remains and The Date Formulas", ISIN Journal 3, 2022 Boissier, Alfred, "Inscription de Naram-Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 16, no. 3, pp. 157–64, 1919 Foster, B. R., "Naram-Sin in Martu and Magan", ARRIM 8, pp. 25–44, 1990 Glassner, J. J., "Naram-Sîn Poliorcète. Les avatars d'une sentence divinatoire", Revue d’Assyriologie et d’archéologie Orientale, vol. 77, no. 1, pp. 3–10, 1983 Grayson, A. Kirk, and Edmond Sollberger, "L’insurrection générale contre Narām-Suen", RA70, pp. 103–128, 1976 Lafont, Bertrand, "Une plaque en argile portant une inscription de Naram-Sin d'Agadé", The Third Millennium. Studies in Early Mesopotamia and Syria in Honor of Walter Sommerfeld and Manfred Krebernik, hrsg. v. Arkhipov, Ilya, Kogan, Leonid, Koslova, Natalia (Cuneiform Monographs 50), pp. 408–416, 2020 Piotr Michalowski, "New Sources concerning the Reign of Naram-Sin", Journal of Cuneiform Studies, vol. 32, no. 4, pp. 233–246, (Oct., 1980) Nassouhi, Essad, "Un vase en albatre de Naram - Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 22, no. 2, pp. 91–91, 1925 [12] A. Poebel, "The ‘Schachtelsatz’ Construction of the Naram-Sîn Text RA XVI 157f.", Miscellaneous Studies, AS 14; Chicago, pp.23–42, 1947 Powell, Marvin A., "Narām-Sîn, Son of Sargon: Ancient History, Famous Names, and a Famous Babylonian Forgery", Zeitschrift für Assyriologie und Vorderasiatische Archäologie, vol. 81, no. 1-2, pp.
In April 1918, after the German-Russian Treaty of Brest-Litovsk, Austrian Foreign Minister Count Ottokar Czernin made a speech attacking incoming French Prime Minister Georges Clemenceau as being the main obstacle to a peace favouring the Central Powers. Clemenceau was incensed and, after seeing Emperor Charles's letter of 24 March 1917, had it published. For a while, the life of Sixtus appeared to be in danger, and there were even fears that Germany might occupy Austria. Czernin persuaded Charles to send a 'Word of Honour' to Austria's allies saying that Sixtus had not been authorised to show the letter to the French Government, that Belgium had not been mentioned, and that Clemenceau had lied about the mention of Alsace. Czernin had actually been in contact with the German Embassy throughout the whole crisis and attempted to persuade the Emperor to step down because of the Affair. After failing to do so, Czernin resigned as Foreign Minister.
Sources: en.wikipedia.org
Reverse-phase HPLC is the usual method and gives a percentage purity value. Mass spectrometry then confirms the molecular mass. Together they provide a basic identity and purity profile for a lot.
Freeze-dried material is kept frozen, often at minus 20 degrees Celsius, and protected from light and moisture. Dissolved peptide is refrigerated for short-term use. Repeated freeze-thaw cycles are avoided.
A certificate of analysis typically lists purity by HPLC, the confirmed mass, appearance, and sometimes water or counter-ion content. It documents results for a specific batch. Details vary by supplier.
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.